LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,809 | -1.9% | 4,386 | +17.7% | 0.03% | +3.4% |
| Q2 2023 | $267,856 | -0.6% | 3,728 | +1.3% | 0.03% | -6.5% |
| Q1 2023 | $269,525 | +16.2% | 3,681 | +36.8% | 0.03% | +3.3% |
| Q3 2022 | $232,000 | +14.9% | 2,690 | +19.1% | 0.03% | +20.0% |
| Q2 2022 | $202,000 | -29.9% | 2,259 | -11.6% | 0.02% | -10.7% |
| Q1 2022 | $288,000 | -29.4% | 2,555 | -3.2% | 0.03% | -30.0% |
| Q4 2021 | $408,000 | +75.1% | 2,639 | +73.0% | 0.04% | +53.8% |
| Q1 2021 | $233,000 | +9.9% | 1,525 | -28.5% | 0.03% | +4.0% |
| Q4 2020 | $212,000 | – | 2,132 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |